Notice of Refund | Nov 20, 2017 | PAPER | BOARD |
Motion For Refund of Post-Institution Fee | Nov 16, 2017 | PAPER | PETITIONER |
Trial Instituted Document | Oct 11, 2017 | PAPER | BOARD |
Exhibit 2001 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2002 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2003 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2004 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2005 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2006 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2007 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2011 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2012 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2013 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2014 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2015 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2016 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2017 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2018 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2029 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2030 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2031 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2019 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2020 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2021 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2022 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2023 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2028 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2032 | Jul 12, 2017 | EXHIBIT | PATENT OWNER |
Preliminary Response | Jul 12, 2017 | PAPER | PATENT OWNER |
Mandatory Notice | Apr 24, 2017 | PAPER | PATENT OWNER |
Power of Attorney | Apr 24, 2017 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Apr 12, 2017 | PAPER | BOARD |
Ex. 1005 - Liversidge et al., U.S. Patent No. 5,399,363 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1006 - Remington's Pharmaceutical Sciences (18th ed. 1990) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1001- Desai et al., U.S. Patent No. 8,853,260 B2 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1003 - Desai et al., U.S. Patent No. 5,439,686 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1004 - Shively, U.S. Patent No. 5,407,683 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1007 - Klein et al., U.S. Patent No. 5,440,056 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1009 - FDA Guideline on Sterile Drug Products Produced by Aseptic Processing (June 1987, reprinted June 1991 and Feb. 1997) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1010 - EMEA Guidance on Manufacture of the Finished Dosage Form (April 1996) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1013 - Elan Pharma Int'l Ltd. v. Abraxis BioScience, Inc., Seventh Day of Trial, No. 06-438-GMS, Dkt. 625 (D. Del. June 10, 2008) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1014 - Grinstaff et al., U.S. Patent No. 5,498,421 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1015 - Patient Information Leaflet, "ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)" (revised May 2007) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1019 - U.S. Application No. 11/520,479, Final Office Action (dated Dec. 29, 2010) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1020 - U.S. Application No. 11/520,479, Amendment After Final Action Under 37 C.F.R. 1.114 (dated Jan. 27, 2012) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1021 - U.S. Application No. 11/520,479, Declaration of Neil P. Desai Pursuant to 37 C.F.R. 1.132 (dated Jan. 27, 2012) ("First Inventor's Declaration") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1022 - U.S. Application No. 11/520,479, Non-Final Office Action (dated May 2, 2013) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1023 - U.S. Application No. 11/520,479, Amendment in Response to Non-Final Office Action (dated Nov. 1, 2013) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1025 - U.S. Application No. 11/520,479, Notice of Allowance and Fee(s) Due mailed Feb. 13, 2014) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1027 - List et al., U.S. Patent No. 5,389,382 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1011 - Elan Pharma Int'l Ltd. v. Abraxis BioScience, Inc., Judgment and Verdict Form, No. 06-438-GMS, Dkt. 614 (D. Del. June 16, 2008) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1012 - Elan Pharma Int'l Ltd. v. Abraxis BioScience, Inc., Sixth Day of Trial, No. 06-438-GMS, Dkt. 624 (D. Del. June 9, 2008) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1016 - Administrative Documents, New Drug Application No. 21-660 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1017 - U.S. Application No. 11/520,479, Non-Final Office Action (mailed Mar. 30, 2010) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1018 - U.S. Application No. 11/520,479, Amendment in Response to Non-Final Office Action (dated Sept. 30, 2010) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1024 - U.S. Application No. 11/520,479, Supplemental Declaration of Neil P. Desai Pursuant to 37 C.F.R. 1.132 (dated Nov. 1, 2013) ("2nd Inventor Declaration") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1026 - U.S. Pharmacopoeia 23 (1995 ed.) (excerpted) ("USP") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1029 - Noureddini et al., "Densities of Vegetable Oils and Fatty Acids," 69 JAOCS 1184 (Dec. 1992) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1032 - FDA Nanotechnology Task Force, "Public Meeting on Nanotechnology Materials in FDA Regulated Products" (Oct. 10, 2006) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1033 - Indian Patent Application No. 2899/DELNP/2005, Applicants' Response to First Examination Report (Jan. 6, 2009) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1028 - Liversidge et al., U.S. Patent No. 5,145,684 | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1030 - FDA, Approved Drug Products with Therapeutic Equivalence Evaluations (33d ed. 2013) ("Orange Book") | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1031 - Grinstaff et al., WO 94/18954, "Methods for In Vivo Delivery of Biologics and Compositions Therefor" (published Sept. 1994) | Apr 4, 2017 | EXHIBIT | PETITIONER |
Petitioner's Power of Attorney | Apr 4, 2017 | PAPER | PETITIONER |
Ex. 1008 - Physicians' Desk Reference 307, 682-85 (49th ed. 1995) "Taxol
(paclitaxel) for Injection Concentrate" | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1034 - Declaration Of Edmund J. Elder, Jr., Ph.D., R.Ph. | Apr 4, 2017 | EXHIBIT | PETITIONER |
Ex. 1002 - Declaration Of Cory J. Berkland, Ph.D. | Apr 4, 2017 | EXHIBIT | PETITIONER |
PETITION FOR INTER PARTES REVIEW | Apr 4, 2017 | PAPER | PETITIONER |